Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

Detalles Bibliográficos
Autores principales: Zhao, Chenyang, Cui, Zhao, Zhang, Yimiao, Wang, Fang, Wang, Xin, Cheng, Xuyang, Meng, Liqiang, Liu, Gang, Zhao, Minghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276299/
https://www.ncbi.nlm.nih.gov/pubmed/34935693
http://dx.doi.org/10.1097/CM9.0000000000001855
_version_ 1784745690908327936
author Zhao, Chenyang
Cui, Zhao
Zhang, Yimiao
Wang, Fang
Wang, Xin
Cheng, Xuyang
Meng, Liqiang
Liu, Gang
Zhao, Minghui
author_facet Zhao, Chenyang
Cui, Zhao
Zhang, Yimiao
Wang, Fang
Wang, Xin
Cheng, Xuyang
Meng, Liqiang
Liu, Gang
Zhao, Minghui
author_sort Zhao, Chenyang
collection PubMed
description
format Online
Article
Text
id pubmed-9276299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92762992022-07-13 Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis Zhao, Chenyang Cui, Zhao Zhang, Yimiao Wang, Fang Wang, Xin Cheng, Xuyang Meng, Liqiang Liu, Gang Zhao, Minghui Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-04-05 2021-12-22 /pmc/articles/PMC9276299/ /pubmed/34935693 http://dx.doi.org/10.1097/CM9.0000000000001855 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Zhao, Chenyang
Cui, Zhao
Zhang, Yimiao
Wang, Fang
Wang, Xin
Cheng, Xuyang
Meng, Liqiang
Liu, Gang
Zhao, Minghui
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
title Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
title_full Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
title_fullStr Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
title_full_unstemmed Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
title_short Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
title_sort leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276299/
https://www.ncbi.nlm.nih.gov/pubmed/34935693
http://dx.doi.org/10.1097/CM9.0000000000001855
work_keys_str_mv AT zhaochenyang leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT cuizhao leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT zhangyimiao leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT wangfang leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT wangxin leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT chengxuyang leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT mengliqiang leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT liugang leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis
AT zhaominghui leflunomidetherapyforadultpatientswithsteroiddependentminimalchangediseaseorprimaryfocalsegmentalglomerulosclerosis

Ejemplares similares